|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/96 | |
| C12N 11/06 | |||
| C12N 9/04 | |||
| G01N 33/66 | |||
| C12Q 1/32 | |||
| C12Q 1/54 |
| (11) | Number of the document | 3126493 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15713455.2 |
| Date of filing the European patent application | 2015-03-27 | |
| (97) | Date of publication of the European application | 2017-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/056732 |
| Date | 2015-03-27 |
| (87) | Number | WO 2015/150263 |
| Date | 2015-10-08 |
| (30) | Number | Date | Country code |
| 14162678 | 2014-03-31 | EP |
| (72) |
HORN, Carina, DE
GAWENDA, Susanne, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
Roche Diabetes Care GmbH, Sandhofer Stra e 116, 68305 Mannheim, DE |
| (54) | HIGH LOAD ENZYME IMMOBILISATION BY CROSSLINKING |
| HIGH LOAD ENZYME IMMOBILISATION BY CROSSLINKING |